SCHEMBL2655848

SCHEMBL2655848

CC(C)CN(C)Cc1ccc(Cl)cc1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PYCR1 P32322 3/20 0.59
SLC6A2 P23975 5/20 0.55
SLC6A4 P31645 5/20 0.55
SLC6A3 Q01959 2/20 0.55
CYP1A2 P05177 2/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
CYP2D6 P10635 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
IDO1 P14902 3/20 0.44
HTT P42858 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MAPK1 P28482 1/20 0.43
POLB P06746 1/20 0.42
KCNH2 Q12809 1/20 0.41
EPHX1 P07099 1/20 0.39
ERCC1 P07992 1/20 0.39
ERCC4 Q92889 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26677103 0.80 PYCR1 (0.65) PYCR1SLC6A2SLC6A4SLC6A3CYP1A2
SCHEMBL2657018 0.80 SLC6A2 (0.52) PYCR1SLC6A2SLC6A4SLC6A3CYP1A2
SCHEMBL13416729 0.79 PYCR1 (0.59) PYCR1SLC6A2SLC6A4SLC6A3TDP1
SCHEMBL2655817 0.79 PYCR1 (0.54) PYCR1SLC6A2SLC6A4SLC6A3CYP1A2
SCHEMBL16553471 0.77 PYCR1 (0.61) PYCR1SLC6A2SLC6A4SLC6A3CYP1A2
SCHEMBL4027414 0.77 MEN1 (0.50) PYCR1SLC6A2SLC6A4SLC6A3CYP1A2
SCHEMBL26675992 0.76 PYCR1 (0.51) PYCR1SLC6A2SLC6A4SLC6A3CYP1A2
Hydrochloric Acid SCHEMBL8648703 0.76 PYCR1 (0.59) PYCR1SLC6A2SLC6A4SLC6A3CYP1A2
SCHEMBL2580840 0.75 PYCR1 (0.48) PYCR1SLC6A2SLC6A4SLC6A3CYP1A2
SCHEMBL23374623 0.74 PYCR1 (0.55) PYCR1SLC6A2SLC6A4SLC6A3HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7196106-B2 Cyanothiophene derivatives, compositions containing such compounds and methods of use MERCK & CO., INC (US) 2007-03-27 US disclosed
US-7196106-B2 Cyanothiophene derivatives, compositions containing such compounds and methods of use MERCK & CO., INC (US) 2007-03-27 US disclosed
US-20040097552-A1 Cyanothiophene derivatives, compositions containing such compounds and methods of use MERCK SHARP & DOHME CORP. 2004-05-20 US disclosed
US-20040097552-A1 Cyanothiophene derivatives, compositions containing such compounds and methods of use MERCK SHARP & DOHME CORP. 2004-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097552-A1 Cyanothiophene derivatives, compositions containing such compounds and methods of use GLP1R, GPR119, GCGR PYCR1 100/4885SLC6A2 771/4885SLC6A4 870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.